In its new guideline, the AGA recommends infliximab, adalimumab, ustekinumab, risankizumab, mirikizumab, guselkumab or ...

T reatment of moderate-to-severe Crohn's disease should prioritize early use of higher-efficacy advanced therapies rather ...

People with Crohn's disease usually experience intense abdominal pain and diarrhea. The pain can be anywhere in the ...

New guidelines recommend doctors tackle Crohn's disease head-on, calling for the use of cutting-edge drugs as early as ...

The American Gastroenterological Association's new guideline uses cutting-edge network meta-analyses to recommend prescribing ...

The American Gastroenterological Association has released updated guidelines for treating moderate-to-severe Crohn’s disease, outlining 16 evidence-based recommendations that prioritize advanced ...

ATHENS, Ga. — Former University of Georgia head football coach Mark Richt and his family are fighting a battle against two ...

The American Gastroenterological Association (AGA) has released a comprehensively updated clinical guideline on the ...

Technology has been rapidly advancing, with digital apps showing promise in IBD management. But are they evidence based? And ...

Market opportunities in the IBD treatment sector include the rising demand for targeted therapies and biologics due to a deeper understanding of the disease, alongside the expansion of biosimilar ...

The U.S. In Vitro Diagnostics (IVD) and Laboratory-Developed Tests (LDT) market for autoimmune diseases is set to witness transformative growth over the next decade. Valued at USD 2.51 billion in 2023 ...

Inflammatory bowel disease (IBD) in children and adolescents represents a rapidly growing field of research within pediatric gastroenterology. Over the past ...